Life Sciences - Australia
What the Team is Known For
King & Wood Mallesons' well-balanced practice operates in the contentious, transactional and regulatory spheres and is particularly noted for its patent litigation offering. The firm is well-placed to act for new and established foreign players in the Australian life sciences market, as well as Australian companies looking to enter the Chinese and other foreign markets and innovative companies seeking to establish themselves. Similarly, its team is well equipped to provide life sciences clients with supporting expertise from all branches of a full-service firm with a particularly strong regional presence.
Strengths
"KWM has outstanding knowledge of the university sector and its intersection with government requirements for commercial and other agreements."
Work Highlights
King & Wood Mallesons acted for Gensco Pharma in relation to the supply of Australian infant formula products in North America to meet significant shortages of infant formula that have been caused by wide-scale recalls by the US Food and Drug Administration due to alleged bacterial contamination.
Notable Practitioners
Matthew Swinn maintains an active IP practice in which he frequently acts for pharmaceutical and medical device companies on patent disputes. He is based in Melbourne. "Matthew Swinn is a very capable lawyer."
Kate Hay focusses much of her practice on the representation of players in the pharmaceutical, bioscience and medical device spheres in key litigation and other IP protection mandates.
Scott Bouvier commands widespread respect for his wide-ranging commercial intellectual property practice, which covers contractual, commercialisation and contentious issues. Clients value his knowledge and experience within the life sciences, acting for pharmaceuticals and researchers. He is based in Sydney.
